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Resum.- En l’article es realitzen unes projeccions per causa de mort, basant-se en aquells models 
que incloguin, en la seva formulació, variables no demogràfiques. La mortalitat total, la 
mortalitat per càncer de pulmó, la mortalitat per causa cardíaca i el suïcidi, es projecten per 
separat, pel període comprès entre finals dels anys setanta-principis dels vuitanta i fins a la 
segona meitat dels anys noranta, per Europa Occidental i Europa de l’Est i per sexe. Les 
projeccions a curt termini es calculen per a 2010. Degut al pas del temps entre l’exposició i 
l’efecte sobre la salut d’una variable particular, per elaborar les projeccions i, pel que fa a les 
variables independents, s’han emprat les dades més recents, mantenint-les constants en tots els 
anys. Els resultats per a la mortalitat total mostren que en la majoria dels països d’Europa 
Occidental, la disminució observada des de finals dels anys setanta es mantindrà pels homes però 
probablement s’estabilitzarà en les dones. Continuarà també el descens en la majoria de països 
d’Europa de l’Est. 
Paraules clau- Mortalitat, Causes de mort, determinants socioeconòmics, model multivariant, 
projeccions, Europa Occidental, Europa de l’Est. 
 
Resumen.- En el artículo se realizan unas proyecciones por causa de muerte, basándose en 
aquellos modelos que en su formulación incluyan variables no demográficas. Se proyecta por 
separado la mortalidad total, la mortalidad por cáncer de pulmón, por causa cardiaca y por 
suicidio, para el período comprendido entre finales de la década de los setenta-principios de los 
ochenta y hasta la segunda mitad de la década de los noventa, para Europa Occidental y Europa 
del Este y por sexo. Las proyecciones a corto plazo se calculan para el 2010. Debido al 
transcurso del tiempo entre la exposición y el efecto sobre la salud de una variable concreta, para 
elaborar las proyecciones y, para las variables independientes, se han utilizado los datos más 
recientes, manteniéndolos constantes en todos los años. Los resultados para la mortalidad total 
muestran que en la mayoría de los países de Europa Occidental, la disminución observada desde 
finales de los años setenta parece mantenerse en los hombres, pero probablemente se estabilice 
entre las mujeres. Continuará también el descenso para la mayoría de países de Europa del Este. 
Palabras clave.- Mortalidad, causas de muerte, determinantes socioeconómicos, modelo 
multivariante, proyecciones, Europa Occidental, Europa del Este. 
 
Abstract.- The main purpose of this paper is to produce cause-specific mortality projections 
from models that include non-demographic variables in its model formulation. Total mortality, 
lung cancer, heart disease and suicide are modelled separately for the period between the late 
1970s/early 1980s to the second half of the 1990s for Western and Eastern Europe and men and 
women. Short-term projections are made to 2010. The models are also validated by comparing 
modelled with observed standardised death rates. Because of the time lag between exposure and 
health effect of a particular variable, which is often a matter of years, current observations for the 
independent variables were used for the projections or when predictions were necessary, the 
latest available value was held constant for the required years. The results for total mortality 
showed that in most Western European countries, the observed decline since the late 1970s is set 
to continue in the near future for men, but is likely to level off among women. The decline that 
has been observed in most Eastern European countries since the mid- to late 1990s is predicted to 
continue. 
Key words.- Mortality, causes of death, socioeconomic determinants, multivariate modelling, 
projections, Western Europe, Eastern Europe. 
 
Résumé.- Le propos principal de ce travail est de fournir des projections de mortalité par cause 
du décès, en utilisant une modélisation qui incluse des paramètres non démographiques. On 
projette de façon séparée la mortalité totale, celle due au cancer du poumon, aux maladies 
cardiaques et au suicide à partir de modèles basés sur les données d’observation sur la période de 
la fin des années 1970-début des années 1980 jusqu’à la seconde moitié des années 1990, pour 
l’Europe occidentale et orientale, et par sexe. Les projections sont à court terme, à l’horizon 2010. 
Les modèles sont validés en comparant les indices de mortalité observés avec les standardisés. 
Du fait du décalage temporel entre période d'exposition au risque et effet sur la santé d'une 
variable particulière, ce qui souvent est une question de plusieurs années, les données des 
variables explicatives furent utilisées pour les projections jusqu'à la période actuelle, et leur valeur 
maintenue constante dans le futur. Les résultats pour la mortalité totale montrent que dans la 
majeure partie des pays d'Europe occidentale, la baisse observée depuis la fin des années 1970 
continuera dans le futur proche pour les hommes, mais probablement s'interrompra ou se ralentira 
pour les femmes. La baisse de la mortalité dans les pays d'Europe de l'Est depuis la fin des années 
1990 devrait se poursuivre dans les années à venir. 
Mots clés.- Mortalité, causes de décès, déterminants socio-économiques, modèle multivarié, 
projections, Europe Occidentale, Europe de l'Est. 
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SOCIOECONOMIC DETERMINANTS OF MORTALITY IN EUROPE:  
VALIDATION OF RECENT MODELS USING THE LATEST AVAILABLE DATA  
AND SHORT-TERM PROJECTIONS 
 
 
1.- Introduction 
The main purpose of this article is to test earlier made models of cause-specific mortality that 
included exogenous variables with the latest available data and to provide short-term projections 
for a selection of European countries. The models, that include separate ones for Eastern and 
Western Europe and for men and women, are derived from the results of research that was 
conducted as part of a PhD thesis (Spijker, 2004). The main objective of this research was to 
“assess the importance of socioeconomic factors on mortality differences across Europe over 
time and between countries or regions to determine which factors should be incorporated into 
future mortality scenarios” (ibid. p. 7). Other factors were only of interest if they intervened in 
the association between socioeconomic factors and mortality, or if their effect was considerable. 
The time frame of the analysis was from the late 1970s/early 1980s to the second half of the 
1990s1. The interest of the PhD research did not lie in the explanation of the disease processes 
leading to death (as this is covered by other disciplines), but in the identification of 
socioeconomic factors that have caused international differences in mortality and changes over 
time. The research framework was therefore set at the macro level for which the analyses 
required aggregated mortality and exogenous data instead of individual-level data that link 
mortality with socioeconomic and other characteristics of the deceased, although individual-level 
studies did form an important basis for the selection of exogenous variables. Both the 
identification of the health-related economic and other variables that ought to be incorporated in 
mortality projections and the quantification of the sensitivity of these variables were the main 
                                                          
1 The two other demographic components, fertility and migration, were dealt with in concurrent projects 
(Jennissen, 2004; Sobotka, 2004). Each project was part of the umbrella project entitled: “Towards a dynamic 
scenario model for economic determinants in population dynamics” that sought to design a new 
methodology to formulate consistent European population scenarios based on the explicit association 
between economic and demographic processes in Europe in order to manifest the consequences of a 
continuation in the socioeconomic development in Europe and the enlargement of the European Union in 
future demographic developments. 
2 
contributions of the thesis and thus made the groundwork for the mortality projections that are 
presented here. 
 
2.- Background 
The improvement that has been made in life expectancy in Western Europe during the latter part 
of the 20th century has been mainly due to rapidly declining death rates in the advanced ages, as 
mortality at young ages was already very low. Epidemiologists consider this period of change the 
fourth phase of the epidemiological transition and have labelled it as the ‘age of delayed 
degenerative diseases’ (Olshansky and Ault, 1986). During this period, a cause-of-death shift 
also occurred within the group of degenerative diseases as the proportion of cancer mortality 
slowly increased at the cost of circulatory system diseases. Conversely, in Eastern Europe, 
countries have remained in the third transition phase of the epidemiological transition, i.e. the age 
of degenerative and man-made diseases, as between the early 1970s and late 1990s life 
expectancy at birth stagnated and even declined in the countries of the former Soviet Union. As a 
consequence, most current East-West mortality differences are reflected in differences in 
circulatory system diseases as well as external causes of death. 
Analysing mortality by cause of death is a first step in the understanding of mortality differences 
over time or space, as its aetiology (cause) provides us with some knowledge of the risk factors 
of the disease. For instance, reductions in behavioural risk factors and improvements in health 
care have been identified as the main determinants for the recent changes in mortality. However, 
although the majority of the most prevalent causes of death have several risk indicators in 
common, a change in one of those risk indicators does not affect each cause of death to the same 
degree, as causes of death may have one or several very important risk indicators. Moreover, 
there may also be variation in time between exposure of a particular risk indicator and its effect 
on different diseases. These are important considerations in both the analyses of mortality 
differences and well as projections.  
While the third and fourth stages of the epidemiological transition served as the general context 
within which the current mortality pattern in Europe is placed, in order to obtain a clear overview 
of the important factors that affect health, the different analyses were set within the framework of 
the life course. Although the studies were ecological in design, it was assumed that also at the 
3 
population level, determinants of health related to the life course could be identified2. For 
instance, the propensity to smoke or other types of risk behaviour do not occur randomly, but are 
determined by a wide range of distal factors throughout life, including both socioeconomic and 
macroeconomic factors. For instance, it has been consistently shown at the level of the individual 
that manual workers show more adverse risk behaviour and are expected to live shorter than non-
manual workers. Therefore, a change or difference in the composition of the population in terms 
of economic structure is also likely cause changes or differences in behavioural risk factors, 
which will be reflected in cause-specific mortality patterns, usually at some later period in time. 
This inherent time delay between the exposure (such as being unemployed) and its (indirect) 
association with mortality is also why the life course approach has been applied to this research, 
as the risk of an exposure accumulates over time. It was considered that by calculating cause-
specific time lags for each variable that was used in the analysis some of this time effect could be 
taken into account. 
It should be mentioned that in any social research study it is impossible to obtain an independent 
effect of each variable because of multicollinearity. Illustrations were therefore also given of how 
associations between one variable and a mortality indicator sometimes dramatically changed 
after including one or several additional variables. This problem is somewhat reduced when a 
wide range of variables are included in the analysis. Moreover, in ecological studies it is not 
possible to control for other factors in the same way as in individual-level studies, but as in each 
multivariate analysis there was a reasonable selection of exogenous variables, the established 
associations were unlikely to be spurious when they coincided with similar results that have been 
found at the individual level.  
 
3.- Data and method 
Given the historical differences in economic development within Europe, it was decided to 
conduct two sets of analyses for the period between the late 1970s/early 1980s and the late 
1990s, namely one for the Western and one for the Eastern European countries (labelled ‘West’ 
and ‘East’). The main source for the national age-, sex- and cause-specific mortality data and 
age- and sex-specific population data was the WHO Mortality Database3. Both the mortality and 
                                                          
2 Although no causal relationship may be inferred at the individual level from an association that may be 
established in the analysis later between a variable and the mortality outcome (Valkonen, 1993; Gravelle, 
1998). 
3 Pertains to the data that were available at 30-01-2001. 
4 
population data were already in, or could be aggregated to, the required 19, generally five-year, 
age intervals (0, 1-4, 5-9, 10-14, …, 80-84, 85+). The mortality data contained causes of death 
that were coded according to the 8th, 9th or 10th revision of the International Classification of 
Diseases (ICD). Causes of death were selected on the basis of its relative importance, the quality 
of its registration and the documented association with socioeconomic factors4. The nine that 
were eventually chosen covered respectively, 83% and 81% of total mortality in the selected 
Western and Eastern European countries (see Tables 1 and 2). Due to international 
inconsistencies in the registration of ischaemic heart disease (IHD) (ICD-9 410-414) and other 
heart disease (ICD-9 415-429), a general heart disease category was formed by subtracting the 
cerebrovascular disease (CRB) deaths from the entire circulatory system disease category. A 
similar aggregation has also been done in the past (e.g. Law and Wald, 1999; Murray and Lopez, 
1996). Moreover, the most important macro-determinants of the specific heart and other 
circulatory system diseases, as well as the symptoms and proximate causes (e.g. hypertension 
and smoking) are similar. Lung cancer and prostate cancer were subtracted from total cancer to 
create the category ‘remaining cancer’. Although this remains a rather heterogeneous cause-of-
death group, containing over 200 types of cancer, the disease process is the same – only the 
location varies. Moreover, they also share important disease determinants such as smoking, 
alcohol consumption and insufficient intake of fibre, fruit and vegetables. 
The explanatory variables for which data could be obtained are, together with their sources, listed 
in Table 3. Data on pollution, unemployment, smoking, fruit and vegetable consumption and 
government health expenditure as a percentage of GDPc could only be acquired for Western 
Europe5. The age-standardised cause-specific death rate (SDRs) that was calculated using the 
1970 WHO standard population for Europe served as the dependent variable6. Pooled cross-
section and time-series analysis was employed to analyse the data, using the statistical 
programme EViews. This tool pools the time-series data for each country in order to obtain a 
data set of N*T observations. By treating time and space as one dimension, the model explains 
the cross-country and inter-temporal variations in mortality simultaneously, producing a single 
effect for each independent variable.  
                                                          
4 This last criterion was in accordance with the main objective of the research on which this paper is based on 
(see Introduction). 
5 Data on the consumption of cereals and government health expenditure in purchasing power parities were 
also obtained, but were shown to be highly correlated with, respectively, fruit and vegetable consumption and 
GDPc. They were therefore excluded from the main analyses. 
6 In due course, the SDRs will be recalculated with the 1990 WHO Standard Population for Europe. 
 Table 1.- Countries and years for which cause-specific mortality and population data were obtained, and their ICD codesa 
 
 
Western Europe 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03
Austria 8 8 8 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 10 10
Belgium 8 8 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9
Denmark 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 10 10 10 10 10 10 10
Former FRG 8 8 9 9 9 9 9 9 9 9 9 9 9 9   
Finland 8 8 8 8 8 8 8 8 8 8 9 9 9 9 9 9 9 9 9 10 10 10 10 10 10 10 10
France 8 8 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 10 10
Greece 8 8 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9
Italy 8 8 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9
Norway 8 8 8 8 8 8 8 8 8 9 9 9 9 9 9 9 9 9 9 10 10 10 10 10 10 10
Sweden 8 8 8 8 8 8 8 8 8 8 9 9 9 9 9 9 9 9 9 9 10 10 10 10 10
Switzerland 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 10 10 10 10 10 10 10
United kingdom 8 8 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 Est 10 10
     
Eastern Europe     
Belarus   9 9 Est Est 9 9 9 9 9 9 Est 9 9 9 9 9 9 9 9 9 9 10 10
Bulgaria   9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9
Former Czechoslovakia   9 9 9 9 9 (9) (9) (9) (9) (9) (9)   
Czech Republic   9 9 9 9 9 9 9 9 10 10 10 10 10 10 10 10 10 10
Slovak Republic   Est Est Est Est Est Est 9 9 10 10 10 10 10 10 10 10 10
Estonia   9 9 Est Est 9 9 9 9 9 9 9 9 9 9 9 9 10 10 10 10 10 10
Former GDR   9 9 9 9 9 9 9 9 9 9   
Hungary   9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 10 10 10 10 10 10 10 10
Latvia   9 9 Est Est 9 9 9 9 9 9 9 9 9 9 9 10 10 10 10 10 10 10 10
Russian Federation   9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 10 10 10 10
Ukraine   9 9 Est Est 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9
 
a In the “year” columns, “8”, “9”, and “10” refer to the mortality data that were classified according to the ICD-8 (A-list), ICD-9 (B-list and country-specific codes for 
Switzerland and the New Independent States), and ICD-10 revisions. The Slovak data for 1986-91 were obtained by subtracting the number of deaths and population of 
the Czech Republic from the data that were obtained for Czechoslovakia. For these years, Czechoslovakia was excluded from the main analysis. Data for missing years 
were interpolated when data for surrounding years were available (e.g. Belarus 1983 = 1982 + 1/3*(1985-1982)). The data were used for the construction of the cause-
of-death models in the original analysis (Spijker, 2004), while the coloured cells indicate the data that were recently obtained for the validation analysis that was 
conducted for this paper. Population data were obtained for the same years as the mortality data. 
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Table 2.- Causes of death selected for analyses, their ICD codes and contribution to total male 
mortality in Western and Eastern Europe between the late1970s/early 1980s and the late 
1990s 
 
Cause of death ICD-8 ICD-9 ICD-10 Westa Easta
  SDR per 100000 
Total mortality 000-E999 000-E999 A00-Y89 1065 1745
Lung cancer 161-162 161-162 C32-C34 7.8% 5.8%
Prostate cancer 185 185 C61 2.5% 0.8%
Remaining cancer Rest of 140-239 Rest of 140-239 Rest of C00-D48 16.0% 10.4%
Cerebrovascular disease 430-438 430-438 I60-I69 9.7% 14.8%
Heart disease Rest of 390-458 Rest of 390-459 Rest of I00-I99 32.0% 36.0%
Respiratory system diseases 460-519 460-519 J00-J99 8.8% 7.2%
Chronic liver disease and cirrhosis 571 571 K70-K76 2.4% 1.5%
Traffic accidents E800-E845 E800-E848 V00-V99 2.2% 2.1%
Suicide E950-R959 E950-R959 X60-X84 1.9% 2.7%
a See Table 1 for the countries in each analysis. 
 
 
In order to capture country-specific elements, such as the effect of the Soviet political system on 
economic and educational factors in Eastern European countries and the former Soviet Union, or 
dietary factors other than the consumption of alcohol, fruit and vegetables, and cereals, dummy 
variables were initially considered as an option. However, due to the frequent occurrence of a 
‘near singular matrix’ in the estimated residual correlation matrix, dummy variables were not 
incorporated. Instead, in order to capture some of the country-specific elements, fixed effects 
were calculated (i.e. distinct intercepts estimated for each country). When results showed a 
structural pattern in the error-term of the model, as indicated by the Durbin-Watson (DW) test, it 
indicated the presence of autoregression (AR) and so an AR(1) term would be included. AR 
means that the probability of a positive/negative error term at time t, following a 
positive/negative error term at time t-1, is larger than that of an error term with a reversed sign. In 
the event of positive autoregression, an error-term at time t that is under- or over-estimated will 
be similarly under- or over-estimated at time t+1. Negative autoregression indicates the opposite: 
an under- or over-estimation of the error-term is followed by an over- or under-estimation. Each 
model also includes a term representing mortality at time t-1, since the level of mortality largely 
depends on the level of the previous year. Since it was assumed that cross-section 
heteroskedasticity was present, cross-section weights were also included.  
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In order to compare the coefficients of the covariates, elasticities were calculated (see Spijker, 
2004: pp. 94-95). Since mortality at time t-1 was included, the models are dynamic ones and 
therefore both short- and long-term elasticities can be determined. Short-term elasticity is a form 
of standardised measure that estimates the relative change in the cause-specific mortality rate as a 
consequence of a relative change in a determinant. Since mortality at time t also depends on 
mortality at time t-1, and therefore in turn on t-2, t-3, etc., any independent variable also has 
long-term effects. For instance, an economic shock such as the sudden emergence of 
unemployment will effect mortality not only in year t, but also in years t+1, t+2, t+3, etc. The 
extent of the long-term effect depends on both the strength of the direct effect and the proximity 
of mortality at time t with that of the previous year. In case an exogenous variable has a large 
long term effect on a particular cause of death, this would be an important fact to consider when 
mortality is projected.  
Before starting the pooled cross-section and time series analysis, lags were calculated for the 
exogenous variables because it was considered that the influence on mortality patterns of 
economic and other variables is usually not contemporaneous, but the result of many years of 
exposure. A common example of this is smoking and lung cancer. Lags, however, are seldom 
incorporated in mortality analysis and, even when they are included, they do not always give the 
desired result (e.g. Judge, 1995). The effect of smoking is better known, as it is a proximate risk 
indicator with a profound impact on population health. Epidemiological research has indicated 
that, for individuals, a substantial decline in smoking levels instigates a fall in IHD mortality 
approximately 15 years later, while for lung cancer the lag is approximately 30 years (Ruwaard 
and Kramers, 1993). Because lags vary according to the a priori outcome, i.e. the cause of death, 
establishing the correct time lags is a difficult process and therefore they have been determined 
by a combination of theoretical reasoning (life course perspective and the aetiology of the 
disease), the available time series and empirical tests. In most cases the method employed was to 
conduct a pooled cross-section and time-series analysis for a range of lags for each variable 
separately that also included mortality at time t-1, an autoregressive term if needed7 and cross-
section weights. The results were then compared and the lag corresponding to the highest value 
was taken as the ‘true’ one. As other, often interrelated, factors were omitted, the association 
between the variable under consideration and the mortality indicator was not always in the 
expected direction. In these instances, the lag with the coefficient closest to zero was selected. 
                                                          
7 The autoregressive term was excluded when it was insignificant in the calculation of one or more of the lags 
in a cause-specific model or when the model had not converged after 1000 iterations at p=0.0001. 
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Due to the rapid economic transformation and larger fluctuations in life expectancy in Eastern 
Europe, it was decided to conduct this lagging exercise separately for the two European analyses, 
though no further distinction was made between men and women. Lag values are given in Table 
3, but a more detailed description of specific outcomes is given in Spijker (2004, pp 95-96). 
For the model validation exercise, two comparisons are made. Firstly between the actual and 
modelled SDRs for the original time series; and secondly, by comparing the modelled values 
with the SDRs that were calculated for the most recent years that the WHO Mortality Database 
currently8 has available but were not represented when the models were constructed (see Table 
1). This second comparative analysis effectively tests implicitly the predictive value of the 
models. For each model, some simple short-term projections (up to 2010) were also made. For 
the purpose of this paper, only the results for total mortality, lung cancer, heart disease and 
suicide are presented and discussed. 
With regard to most exogenous variables, data for additional years had to be obtained in order 
to be able to conduct the model validation exercise and make the short-term projections, but 
this particularly concerned those variables for which no or a small time lag was incorporated. 
In case no new data could be obtained, own estimations were made. Some of the original data 
sources also contained updates, including improved estimates of data that were used in the 
construction of the original models (in particular with regard to alcohol consumption). Several 
other adjustments were also made. Firstly, it was decided to employ the natural log of GDP 
per capita rather than the actual value as done earlier, because it is generally considered that 
the additional health effect of a certain amount of income decreases with increasing income. 
Secondly, the smoking variable was not judged to be very accurate for modelling purposes, 
because annual consumption for a population is a period measurement and does not represent 
life-time exposure. Neither do the data distinguish between smokers and non-smokers and the 
eventual sex-specific values were estimated from total consumption and male and female 
smoking prevalences. Although the introduction of time lags partly accommodated life-time 
exposure, the smoking data, often with own estimates, did not go further back than 1960, 
making it difficult to estimate meaningful lags.  
 
The observed lung cancer mortality rate was therefore considered to be a more appropriate 
smoking indicator9 and so it was included for the same smoking-related cause-of-death models 
                                                          
8 Mortality data as of 04-03-2005. 
9 This has also been done before (see e.g. Barendregt et al., 2002) 
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as before, except for lung cancer itself for which the original variable was used. In this way, it 
was also possible to test the influence of tobacco on Eastern European mortality. The scenario 
estimates for lung-cancer were subsequently used to estimate the other smoking-related causes of 
death (including total mortality). Thirdly, with regard to total mortality and heart disease, the 
protective and detrimental effects of alcohol were tested simultaneously, rather than choosing the 
most influential of the two, as was done in the original research: for the Western European 
analyses only the long-term protective effects of alcohol were tested (which is thought to reduce 
the risk of the thickening of the arteries, a risk factor of IHD) by lagging the variable by 15 years, 
and for Eastern Europe only the short-term detrimental effects of alcohol (e.g. the increased risk 
of sudden IHD and stroke due to “beer bingeing”) were considered. Finally, there were some 
changes in the lags that were used, the most important one being that the lag for unemployment 
now coincided with the one for the two employment variables, because the employment structure 
is influenced by changes in (structural) unemployment. 
Using the original sample of countries and years but with the updated and corrected data and 
other changes, the data were remodelled. Besides the fact that the rerunning of the models gave 
different variable coefficients than before, most models did not have exactly the same 
components as before. Due to the correlation between related variables (e.g. between industrial 
employment and GDPc), the inclusion (or alteration) of one may make another variable 
insignificant. Models were even more sensitive when there was a high level of autocorrelation. 
This was one reason why the outcomes of both the “saturated” and “best models” were given in 
the PhD thesis, but for projections it makes little sense to include all variables when just a few are 
relevant. However, it is nevertheless important to bear in mind that what a variable “represents” 
is more general than the measurement itself. To give an example, the proportion of the workforce 
in secondary sector employment is not just a pure labour variable, but also represents other 
aspects, such as socioeconomic development (countries with a high proportion of industrial 
employment usually have a lower GDPc and a less well educated population than countries with 
a larger service sector), and even behaviour (manual labourers are generally less health 
conscious, as they smoke and drink more and eat less healthy food). As the less reliable smoking 
variable was replaced by sex-specific lung cancer mortality rates as a proxy for lifetime smoking, 
the association between the other variables and mortality that are also associated with smoking 
changes as smoking is better controlled for. The most profound differences with regard to the 
original models as a result of the latest changes include: 
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i. The Eastern European models that now contained the new smoking variable. 
ii. Male total mortality in Western Europe. The smoking proxy caused the dietary factor 
fruit and vegetable consumption to become insignificant. The inclusion of alcohol 
consumption without a lag caused the previous significant association between divorce and 
total mortality to disappear.  
iii. Female total mortality model in Western Europe. The appropriateness of introducing 
lung cancer as a separate variable is demonstrated here, as in the original model tobacco 
consumption was not significant and even negatively significant in the model that included all 
variables. 
iv. With regard to heart disease has alcohol also a long-term protective effect in Eastern 
Europe at the population level and a detrimental short-term effect in Western Europe. 
v. Due to the use of different sources (surveys vs. census), changes in definitions, and lack 
of long time series of the employment structure variables, it was impossible to construct a 
consistent and international and time comparable database. Moreover, the short time series 
did not allow for the computation of an appropriate lag. Nonetheless, when the association 
between industrial or agricultural employment and mortality was significant, its direction was 
consistent with the literature. 
vi. The Western European models for women appeared least similar to the original ones. 
 
The updated model results form the basis of the model validation exercise and the projections: 
 
4.- Results I: the original cause- and sex-specific models for Western and Eastern Europe 
In the original analysis, the results of two types of models were presented: ‘complete’ models 
that included all selected exogenous variables, designed to determine the validity of a series of 
theoretical premises; and ‘best’ models that only included the statistically significant variables for 
the purpose of scenario making. However, to reduce the size of the paper, reference is only made 
to the best models and the variable elasticity tables are left out. The same applies to the 
discussion of age-specific and country-effects, although the latter ones are given in the tables. 
 
  
Table 3.- Overview of exogenous variables and their sources 
_________________________________________________________________________________________________________________________________________________________
_______________ 
Variable Abbreviation Measured as Source 
_______________________________________________________________________________________________________________________________________________________________________
_ 
 
Per capita Gross Domestic Product GDPc Geary Khamis PPPs in 1990 US$ 1 
Income inequality GINI A value between 0 and 1 indicating the distribution of income 2 
Education EDU Number of years of education 3 
Secondary sector employment IND % of the labour force employed in the secondary sector  4 
Primary sector employment AG % of the labour force employed in the primary sector 4 
Divorce DIV Divorce Rate per 100 marriages 5 
Alcohol ALC Alcohol consumption – litres of pure ethanol per person per year (age 15+) 6, 11 
Pollution POL Sulphur Oxides (1000 tonnes) per km2 7,8 
Urbanisation URB Percentage of the population resident in urban areas. 9 
Unemployment UNEMP Total unemployed as % of labour force 10 
Smoking TOBAC Tobacco consumption – grams per person per year (age 15+) 11 
Fruit FRUIT Average amount of fruits and vegetables available per person per year (kg) 12 
Cereals CEREAL Average amount of cereals available per person per year (kg) 12 
Health Care (GDP) HCGDP Governmental expenditure on health as a % of GDP 11 
Health Care (PPP) HCPPP Governmental expenditure on health in PPPs per capita 12 
_______________________________________________________________________________________________________________________________________________________________________ 
1. Groningen Growth and Development Centre (2005); Maddison (2001); OECD (2005a) 
2. WIDER (2000; 2004); World Bank (2002). Other sources include: for Switzerland, Flückiger (2002); for Norway, Statistics Norway (1999); for several Eastern 
European countries, Svenjar (2001); for Russia and the Ukraine, Gregory (date unknown). 
3. Barro and Lee (2000). For most countries, the data covered the period 1960-1990/2000 at five-year intervals. The intermediate years were fitted by means of a 
first-and-second order function. 
4. Data for Western Europe were obtained from Eurostat (2002); for Eastern Europe from ILO (2002); for former Czecholovakia from Federální Statistický Úřad 
(various years); for the Czech Republic from Český Statistický Úřad (various years). Updates from OECD (1999; 2004) 
5. For most countries, data were obtained from Eurostat (2002; 2005); for the USSR successor states, Czechoslovakia and West Germany, some data were obtained 
from the Council of Europe (2001) and CIS STAT (1998). 
6. Tekin (2002); Treml (1997); WHO (1999; 2004). 
7. Lefohn et al. (1999). 
8. Eurostat (2002); OECD (2005b) 
9. United Nations (2004). 
10. For Belarus, Bulgaria, the Czech Republic, Hungary, Latvia and the Slovak Republic registered unemployment; source Western Europe: OECD (Main Economic 
Indicators) and Eurostat (Eurostatistics, ESVG-Aggregates) in: Gärtner (1999); source Eastern Europe: ILO (2002); source Ukraine: CIS STAT (1998); source 
updates: European Commission (2005) 
11. OECD (2001; 2005b); 12. WHO (2002; 2005). 
  
Table 4.- Variable-specific lags (in years) applied to the variables in the pooled cross-country and time-series analysesa 
 
 
 Western Europe 
     
Gdp – Gini + Edu – Ind + Ag Urb Div + Alc Unemp + Lung can + Pol + Fruit – Cereals – Hcgdp – Hcppp – 
Total 15 10 15 5 5 0 10 0/15 5 0 10 5 5 1 1 
Lung 15 10 15 5 5 0 10 5 5 10 (tobac) 10 5 5 1 1 
Prostate 15 10 15 7 7 0 10  7 0 6 6 3 3 
Cancer_rem 15 10 15 5 5 0 10 5 5 0 5 5 2 2 
Heart 15 10 15 5 5 0 10 0/15 5 0 10 7 7 5 5 
Crb 15 10 15 0 0 0 10 0 0 0 5 5 1 1 
Resp 15 10 15 7 7 0 10 10 7 0 15 5 5 1 1 
Ldc 3 3 15 3 3 0 10 0 3 5 5 1 1 
Traffic 1 0 0 0 0 0 3 0 0 5 5 
Suicide  5 0 0 0 0 1 0 0 5 5 
 
 Eastern Europe 
     
Total 0 0 10 7 7 0 1 0/15 1 0   
Lung 10  10 5 5 0 10 10   
Prostate 15  15 10 10 0 10  0   
Cancer_rem 10  10 10 10 0 10 10 0   
Heart 0 1 15 10 10 0 1 0/15 0   
Crb 0 0 15 3 3 0 1 0 3 0   
Resp 10 5 15 5 5 0 1 0 0   
Ldc 0 0 15 5 5 0 1 0 1   
Traffic 1 0 0 0 0 0 5 0 0   
Suicide 0 0 0 0 0 0 0 0 0   
 
a The sign next to a variable indicates documented directions of association. In the case of agriculture and urbanisation, there is no clear uniform pattern, while alcohol 
was considered to be negatively associated with heart disease and positively to the other causes of death. 
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Table 5.- Results from the pooled model for the different causes of death:“West” analysis  
Men total cancer_rem
Cause at t-1 0,84 *** 0,90 *** 0,71 *** 0,86 *** 0,86 *** 0,76 *** 0,21 *** 0,86 *** 0,65 *** 0,86 ***
lnGDPc -35,51 *** -1,56 ** 1,74 *** -8,79 *** -38,24 *** -4,29 **
GINI 0,92 ** 0,29 * 0,07 *** 0,02 **
EDU -7,67 *** -0,57 ***
IND 0,87 * 0,21 ** 1,01 ** 0,41 *** 0,18 *** 0,04 **
AG -0,19 ** -1,33 *** 0,67 *** -0,26 ** -0,12 ***
DIV 0,03 *** 0,08 ** 0,49 *** 0,03 **
ALC+ 4,14 *** 0,44 *** 1,21 *** 0,90 *** 0,55 *** 0,15 * 0,09 ***
ALC- -0,95 ***
POL 2,25 ** 0,36 *** 1,44 * 5,72 ***
URB -0,34 *** -0,28 ***
UNEMP 0,06 * 0,24 *** 0,02 * -0,16 **
LUNG 0,77 *** 0,37a * 0,02 ** 0,04 ** 0,20 * 0,17 *** 0,17 **
FRUIT -0,01 ** -0,02 **
HCGDP -0,24 ** -0,58 ** -0,40 *
AR(1) -0,47 *** -0,32 *** -0,34 ***
Fixed Effects
Austria 345,15 41,56 -8,47 13,92 56,12 64,49 346,54 -3,40 65,67 7,46
Belgium 295,04 51,46 -8,32 10,43 13,64 50,89 322,82 -7,19 74,72 6,59
Switzerland 342,43 40,55 -6,32 13,93 41,14 57,38 367,96 -7,58 62,60 7,45
West Germany 323,91 46,45 -7,94 14,01 37,94 59,57 327,83 -6,02 67,92 5,36
Denmark 363,02 48,64 -8,26 16,04 59,08 58,63 357,49 -6,02 69,72 7,70
Finland 371,59 38,83 -8,01 11,65 58,08 66,57 382,00 -4,09 64,22 9,69
France 312,06 45,49 -8,78 15,64 24,39 50,00 345,07 -8,88 68,05 5,82
Greece 316,24 41,95 -11,26 19,51 46,34 70,18 314,46 -7,51 70,26 5,37
Italy 317,86 44,29 -10,96 16,81 17,87 61,15 351,35 -5,44 66,60 3,26
Norway 401,03 43,38 -5,17 17,57 58,60 76,32 386,58 -3,52 66,60 7,36
Sweden 391,53 46,09 -6,59 14,16 64,41 70,65 368,06 -4,04 66,86 7,04
United Kingdom 326,39 46,02 -10,13 10,81 26,54 60,50 363,82 -6,15 66,04 4,23
Durbin-Watson 2,02 2,13 2,29 2,01 2,37 2,28 2,13 2,11 2,22 2,19
R2 adj 98,92 99,75 98,44 99,81 98,85 98,36 94,61 99,51 96,57 97,65
lung prostate heart CRB suicideresp LDC traffic
 
 
 
Women total cancer_rem
Cause at t-1 0,64 *** 0,79 *** 0,79 *** 0,91 *** 0,90 *** 0,79 *** 0,18 *** 0,80 *** 0,56 *** 0,83 ***
lnGDPc -64,32 *** 1,16 *** -11,72 *** -30,87 *** -1,29 * -0,84 ***
GINI 0,26 ** 0,14 * 0,02 ***
EDU -0,57 ** -1,75 * -0,22 *
IND 3,35 *** 0,07 ** 0,20 *** 0,50 ** 0,61 *** 0,11 *** 0,05 ***
AG -2,23 ** 0,07 *** -0,22 *** -0,17 *** -0,65 ** -0,46 * -0,10 ** -0,07 ***
DIV 0,38 ** 0,02 *** 0,04 *** 0,12 *** 0,28 *** 0,01 ** 0,01 **
ALC+ 4,25 *** 0,12 ** 0,89 ** 0,33 * 0,41 *** 0,26 *** 0,05 * 0,05 ***
ALC- -0,86 ***
POL 3,43 *** 1,97 ***
URB 0,10 *** -0,20 *** -0,28 ** 0,05 *** -0,07 ***
UNEMP 0,12 ** 0,17 ** 0,55 *** 0,01 **
LUNG 0,75 * 0,24a ** 0,66 ***
FRUIT -0,13 *** -0,01 * -0,01 *** -0,02 *
HCGDP -0,07 ** -0,41 *** -0,21 **
AR(1) -0,32 *** -0,37 *** -0,35 ***
Fixed Effects
Austria 673,27 -15,47 12,49 16,51 15,23 105,79 298,90 -4,17 17,53 9,57
Belgium 638,89 -18,81 13,60 21,52 5,57 101,17 293,63 -6,71 20,20 9,75
Switzerland 661,99 -15,96 14,08 14,83 5,39 103,68 313,35 -5,63 17,06 10,19
West Germany 629,37 -17,80 13,17 19,48 7,41 100,13 298,60 -5,71 18,07 8,90
Denmark 693,63 -13,39 15,08 23,25 12,83 102,43 307,85 -5,77 19,04 10,49
Finland 698,48 -15,99 11,51 16,01 12,56 106,30 312,22 -4,43 17,32 10,06
France 625,02 -17,52 12,02 16,49 3,89 98,60 304,06 -6,58 18,65 9,23
Greece 744,75 -16,02 17,28 20,62 22,05 128,92 293,78 -5,54 19,89 9,33
Italy 682,28 -15,91 13,68 18,09 6,84 108,72 300,07 -4,25 17,47 8,41
Norway 708,74 -15,70 11,99 20,46 11,97 108,91 328,98 -4,36 17,90 10,04
Sweden 678,09 -17,37 11,11 20,41 12,39 101,92 316,27 -5,10 18,20 9,71
United Kingdom 642,36 -14,48 12,12 20,30 4,96 102,21 319,89 -6,05 16,93 8,20
Durbin-Watson 2,45 2,39 2,46 2,10 2,10 2,29 2,10 2,01 2,11 2,24
R2 adj 98,83 99,59 99,33 99,83 99,42 98,89 94,58 99,21 97,20 97,56
Method: GLS (Cross Section Weights)
Sample: 1977 1999; Total panel (unbalanced) observations 243
* p< 0.10; ** p<0.05; *** p<0.01 (one-sided)
a Coefficient for the tobacco variable, multiplied by 1000.
lung breast heart CRB suicideresp LDC traffic
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Table 6.- Results from the pooled model for the different causes of death:“East” analysis 
 
 
Men total cancer_rem
Cause at t-1 0,61 *** 0,82 *** 0,52 *** 0,51 *** 0,68 *** 0,71 *** 0,55 *** 0,34 *** 0,69 *** 0,61 ***
lnGDP -61,31 * 3,77 *** -27,01 * 7,43 *** -9,72 ***
GINI 2,94 ** 1,48 ** 0,21 ***
EDU -28,08 * -3,41 *** -18,11 ** -3,43 * -5,37 *** 5,23 ***
IND 0,94 *** 6,36 *** 1,29 *** 0,46 * 0,18 *** 0,36 *** 0,48 ***
AG -0,12 * 0,34 ***
DIV 0,23 *** 0,18 * 0,17 *** 0,24 ***
ALC+ 19,95 *** 0,81 *** 0,40 *** 5,56 *** 2,05 *** 1,11 *** 0,70 *** 0,25 * 0,47 **
ALC- -2,39 *
LUNG 3,79 *** 0,35 *** 0,37 * 0,36 ***
URB 11,40 *** 0,71 *** 0,15 *** -0,40 * 1,66 *** -2,57 ***
UNEMP 0,19 ***
AR(1) 0,61 ***
Fixed effects
Bulgaria 6,33 -17,83 -35,99 16,36 182,81 -92,12 191,64 -3,77 -116,79 56,15
Belarus 98,31 -5,81 -36,32 30,91 272,30 -97,97 209,40 -8,66 -119,57 63,58
Czech Republic -223,03 -12,09 -32,33 36,17 162,38 -131,48 189,22 -4,09 -127,35 57,79
Czechoslovakia -108,19 -6,78 -33,32 28,02 156,25 -114,72 194,91 -0,48 -127,26 59,47
East Germany -170,40 -21,50 -35,56 26,38 231,62 -151,80 223,79 -1,58 -128,11 67,14
Estonia -45,74 -14,49 -34,42 28,79 240,79 -104,47 170,98 -9,68 -114,58 67,74
Hungary -127,94 -4,13 -28,46 37,62 184,63 -104,22 155,25 38,41 -116,30 68,77
Latvia -98,26 -13,84 -34,76 29,20 220,73 -95,43 171,45 -13,84 -110,47 65,85
Russia -93,79 -10,34 -39,06 30,14 200,29 -88,21 211,47 -11,30 -120,88 66,17
Slovak Republic 2,75 -2,57 -31,65 32,40 195,87 -112,74 162,19 7,78 -120,95 60,07
Ukraine 26,55 -7,80 -37,03 24,66 246,24 -90,45 208,01 -2,33 -118,61 57,30
Durbin-Watson 1,64 2,04 2,11 2,32 1,76 1,91 2,00 1,99 1,75 1,88
R2 adj 99,2708 99,801 99,102 99,906 99,489 98,371 92,814 97,70 93,533 97,465
lung prostate heart CRB suicideresp LDC traffic
 
 
 
Women total cancer_rem
Cause at t-1 0,71 *** 0,87 *** 0,72 *** 0,67 *** 0,66 *** 0,78 *** 0,44 *** 0,61 *** 0,57 *** 0,63 ***
lnGDP 1,22 *** -7,05 *** -23,01 ** 12,75 *** 0,96 ** 2,33 *** -1,00 ***
GINI 1,68 *** 0,76 ** 0,07 *** 0,03 ***
EDU -28,40 *** -0,34 *** 1,19 *** -1,56 *** -15,70 *** -4,36 *** -2,59 *** 0,64 ** -0,02 ***
IND 2,24 * 0,08 ** 0,55 *** 3,64 *** 0,31 ** 0,51 *** 0,09 *** 0,13 *** 0,11 ***
AG 0,11 ** 0,37 ** 0,11 *** 0,10 ***
DIV 0,09 ** 0,03 *** 0,01 ** 0,04 ***
ALC+ 6,31 *** 0,08 *** 0,35 *** 1,19 *** 0,24 *** 0,21 *** 0,03 **
ALC- -2,61 ***
LUNG 0,79 ***
URB 4,79 ** 0,21 *** 0,88 *** -2,73 *** 0,15 *** 0,15 **
UNEMP 0,03 **
AR(1)
Fixed Effects
Bulgaria -37,47 -7,57 -22,59 73,93 300,79 -9,96 78,52 -26,94 -41,74 4,72
Belarus 25,90 -7,46 -25,02 80,31 342,12 -7,87 84,89 -26,87 -41,20 4,43
Czech Republic -79,31 -6,30 -23,45 90,96 295,12 -24,35 89,17 -27,62 -45,18 4,61
Czechoslovakia -32,83 -7,13 -21,53 87,69 291,07 -16,02 89,18 -26,34 -44,54 4,76
East Germany -67,17 -7,49 -23,93 84,33 354,24 -37,81 113,53 -27,02 -44,69 6,59
Estonia -60,65 -8,08 -21,67 86,27 313,61 -15,01 68,29 -28,82 -41,59 6,07
Hungary -12,68 -5,38 -17,83 90,72 324,13 -17,77 54,61 -16,98 -41,10 8,68
Latvia -62,58 -8,02 -21,53 84,31 313,51 -10,12 71,60 -28,63 -40,54 6,39
Russia -42,39 -7,39 -25,12 82,73 318,62 0,70 96,43 -28,03 -43,16 5,88
Slovak Republic -0,23 -7,38 -20,52 84,18 322,32 -20,93 57,52 -22,77 -41,36 3,94
Ukraine 18,36 -7,05 -23,82 78,34 345,86 -2,23 83,10 -25,69 -41,51 4,15
Durbin-Watson 1,87 2,31 2,34 2,23 1,95 1,90 2,01 2,03 1,90 2,27
R2 adjusted 99,23 99,31 99,61 99,93 99,16 98,69 94,11 95,13 94,09 98,33
Method: GLS (Cross Section Weights)
Sample: 1981 1999; Total panel (unbalanced) observations 206
* p< 0.10; ** p<0.05; *** p<0.01 (one-sided)
lung breast heart CRB suicideresp LDC traffic
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As the results indicate, each model fitted the data very well: the adjusted R2 values ranged from 92.8% 
to 99.9%. In fact, it appeared that both mortality at time t-1 and the exogenous factors were 
independently able to accurately predict mortality. The contribution of mortality at time t-1 is not 
surprising however: most deaths are the result of lifetime accumulations of health risks and exposures 
and therefore the probability of death will not fluctuate that much from year to year. 
The R2 values also remained about the same in each model when mortality at time t-1 was removed 
(not shown here), but this term was retained in order to obtain a better estimate of the effect of the 
exogenous variables. Without it, models showed high negative autocorrelations, even with an 
additional AR(1) term. The high R2 was also in part due to the inclusion of cross-country weights (to 
eliminate cross-section heteroskedasticity) and fixed effects (i.e. country-specific intercepts).  
One point to bear in mind when interpreting the results is that, in many instances, the exogenous 
variables have been lagged by different times depending on the cause of death and also by different 
amounts in Eastern and Western Europe. In regard to the latter, the effect on mortality of several of the 
variables appeared to be more immediate in Eastern than in Western Europe. This was particularly the 
case with absolute and relative income and divorce. GDPc, the proportion of the workforce employed 
in the industrial sector and the amount of alcohol consumed were the variables that were most 
frequently significant. Agricultural employment, divorce and smoking can be added to this list for 
Western Europe, and education and urbanisation for Eastern Europe.  
Results for men showed that GDP per capita (GDPc) was significant in six out of the ten models in 
both Eastern and Western Europe, but its elasticity for total mortality was higher in Eastern Europe, 
something which was expected given the fact that GDPc and mortality are not linearly associated and 
therefore health gains in the poorer East are greater with an equal amount of extra wealth. Among both 
sexes, the Eastern European results also showed that GDPc was significant in two of the models 
pertaining to causes of death that have been linked with psychosocial factors, i.e. heart disease and 
suicide, while in the Western European analysis, these causes were only associated with relative 
prosperity. The association between GDPc and traffic accidents was positive rather than negative in 
Eastern Europe, perhaps because cars were a luxury product for most people. For women, GDPc also 
showed a positive association with lung cancer, thus indicating that for them it is still a welfare disease. 
These different results imply that the effect of GDPc on health appears is not the same between the two 
Europe’s and to some extent between men and women.  
In the models for Western Europe, income inequality was also significant for chronic liver disease and 
cirrhosis (LDC) and respiratory system diseases, although in each instance its absolute effect on 
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mortality was low, as often other, related factors (GDPc, unemployment) were also significant. In the 
“East” analysis income inequality also had an impact, even on total mortality, something that did not 
occur in Western Europe. Given the fact that during the socialist period there were few international 
differences in income inequality, this result was less expected and shows that it takes little time before a 
sudden rise in income inequality affects mortality at the population level.  
In both Europe’s and for men and women, the proportion of industrial employment in the workforce 
was an important explanatory factor in the models of remaining cancer, heart disease, CRB, traffic 
accidents and suicide, as well as for total mortality in Western Europe and LDC and respiratory system 
diseases in Eastern Europe. On each occasion it was significant, it demonstrated a detrimental effect, 
also after including other risk factors like smoking or alcohol consumption. Although the effect of 
improved occupational safety standards independent of the employment structure could not be tested, it 
seems more likely that the improvement (or difference) in wealth emanating from the larger (different) 
share in service sector industries was associated with health, rather than the factors inherent to social 
class differences in health, as in the instances when industrial employment was not significant it 
occurred after including GDPc (e.g. male lung cancer in Western Europe). While short-term elasticities 
were quite low, particularly in the Western European models, the long-term effect of industrial 
employment on mortality was more substantial, particularly for remaining cancer, heart disease and 
traffic accidents (results not shown). When agricultural employment was significant, the association 
was usually negative with mortality in Western Europe and positive in Eastern Europe and rural life 
seemed to benefit particularly Western European women. 
At the population level the effect of unemployment on mortality was minor. This was explained by the 
fact that the low level of unemployment in the Western European countries that were studied (after 
lagging it 15 years, the average was just 3%) a very high relative risk is needed to have some bearing 
on international mortality differences or changes over time. However, given the increases in 
unemployment since the 1980s and its recent emergence in Eastern Europe, unemployment is likely to 
become a more important factor.  
The importance of education as an independent health-promoting factor associated with the acquisition 
of knowledge related to health-damaging behaviours rather than just economic development was 
perhaps more evident in Eastern than in Western Europe. This was because when GDPc also showed a 
significant protective effect in the models of total mortality, heart disease and suicide, education was 
negatively significant. A clear independent association of education in the analyses of Western Europe 
was established for breast cancer, heart disease and suicide. The first two associations suggest that 
health-related knowledge, both in terms of behaviour and the ability to optimise the use of health 
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services might be indispensable in the fight against these diseases. It should be mentioned that with 
regard to the Eastern European models for traffic accidents, the association with education was 
positive, which may therefore be related to prosperity.  
The only social factor that was tested was divorce. While mortality has been declining in Western 
Europe between the late 1970s and late 1990s, the level of divorce has seen a steady increase and 
indeed divorce appeared to have had a significant counter effect on this trend regarding several of the 
selected causes of death, particularly for women. A future consequence may therefore be that in those 
countries where divorce is still a recent or minor phenomenon (particularly in southern Europe) 
continued increases in divorce are likely to have an impact on future levels of mortality. Results of the 
analysis also showed that the magnitude of the effect of divorce was larger in Eastern Europe than in 
the West, which was perhaps the result of higher general levels of psychosocial stress (not shown). 
Although the literature suggests that divorce is more detrimental to the health of men than that of 
women, at the population level, the elasticities were very similar (results not shown). 
The models also included several behavioural factors. The results showed that at the population level, 
two types of associations exist between the consumption of alcohol and mortality: negative in the long 
term with regard to heart disease and a positive (i.e. detrimental) short/intermediate term effect for most 
other causes of death, including total mortality, as well as heart disease in Eastern Europe, i.e. alcohol 
showed both effects there. The positive short-term association with both total and heart disease 
mortality is possibly because of traditions in “binge drinking” that is known to elevate the risk of 
sudden IHD. The effect of smoking was measured by the association of lung cancer mortality with the 
specific cause of death category (except for lung cancer itself of course, in which case the less reliable 
tobacco consumption variable was used for Western Europe (there was no data for Eastern Europe). 
Results showed that smoking had the largest impact on differential mortality for Western European 
men, being significant for all natural causes of death for which it was tested, although in Eastern 
Europe it was significant for total mortality, remaining cancer, heart disease, and respiratory system 
diseases. Among women, it particularly lacked an association with circulatory system diseases. 
Although most countries had their smoking peak around 1980, towards the end of the 1990s country 
differences were just as large as in 1960. Given the time delay that it takes for smoking to have a fatal 
impact on health, it is expected that smoking will continue to be an important factor in mortality 
differences between countries in Europe well into the 21st century, particularly for women where the 
effect is just being felt. The effect of fruit and vegetable consumption could only be tested for Western 
Europe and results were as expected, as significant effects were found for total mortality and breast 
cancer (both women only), lung (men only) and remaining cancer. As the west and north of Europe 
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still lag behind in consumption levels compared to southern Europe more health gains can still be made 
there. This of course applies even more to Eastern Europe and the former Soviet Union. Due to 
insufficient data, the two other variables, pollution and government health expenditure, could only be 
tested for Western Europe, but they only had a small effect on mortality at the population level.  
 
5.- Results II: model validation and short-term projections for lung cancer, heart disease and 
suicide 
The models were validated by comparing the observed with the modelled SDR’s for each country and 
year that the model calculations were based on. The general model is given by the equation: 
 
SDRcst  = Ci + Σ βXj,t-x,i + μ t , where  
 
 
SDRc = the standardised death rate for cause of death c 
s = sex 
t = year 
C = fixed effect 
i = country i 
Xj = the dependent variable j 
β  = the model coefficient of the dependent variable Xj 
x = the lag time (in years) 
μ  = the disturbance term10 
 
Considering the model results in Table X, the general male lung cancer mortality model for Eastern 
Europe is therefore equivalent to: 
 
SDRlung,t,i = Ci + 0,8157*SDRlung,t-1,i – 3,4103*EDUt-10,i + 0.8083*ALC t-10,i + 0,7103*URB t,i  
 
From this model we can subsequently estimate the lung cancer mortality rate in one of the modelled 
countries for any of the years during the study period (except the first year) with the known observed 
level of the year before and the specified exogenous characteristics at time t - lag x. For instance, the 
modelled lung cancer rate for Bulgaria in 1999 would be: 
                                                          
10 When the autoregressive term AR(1) is included in the model, μt  = ρμt-1 + εt, where ρ is the first order serial correlation 
coefficient and εt the innovation in the disturbance. In effect, the AR(1) model incorporates the residual from the past 
observation into the regression model for the current observation (see Quantative Micro Software, 1994: pp. 301-3).  
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SDRlung,1999,BG  = -17,83 + 0,8157*61,46 – 3,4103*8,58 + 0,8083*11,75 + 0, 7103*68,62 
  = 61,28 
 
The actual value equalled 62,26, which amounts to a difference (disturbance) of 0,98 deaths per 
population of 100,000 or 1,6%. The results for total mortality, lung cancer, heart disease and suicide are 
given in Figures 1-4. 
The predictive value of the models could be tested with the additional mortality data that were recently 
obtained by comparing the latest mortality figures with their modelled equivalents. These were 
calculated by introducing the required variable values into the earlier-made models. To illustrate this 
with the same example as before, the observed lung cancer rate for Bulgaria in 2003 was 65,06. 
According to the model this should have been: 
 
SDRlung,2003,BG  = -17,83 + 0,8157*63,07 – 3,4103*9,08 + 0,8083*10,10 + 0, 7103*69,75 
  = 60,63 
 
Due to the (lagged) increase in education and (lagged) decrease in alcohol consumption, lung cancer 
mortality should have declined during these four years, but it increased instead, suggesting some 
underspecification of the model. The subsequent male lung cancer mortality scenario for Bulgaria may 
therefore not be very realistic. Nevertheless, as we shall see, for both total mortality and the three 
causes of death investigated, the differences between the modelled and actual values are generally 
small. The sometimes unrealistic projections, like the one mentioned here, may therefore be due to 
unlikely projected values for some of the exogenous variables that were often estimated by the author. 
Obviously, one reason why the disturbances are often small is due to the fact that previous year’s 
mortality was included in the model. Therefore, when differences were large and fluctuated from being 
positive to negative this was in part due to large yearly fluctuations in mortality and/or the exogenous 
variables. It was perhaps therefore that the most accurate models appeared to be for the countries with 
the largest populations and those of Western Europe, as this was where the year-to-year mortality 
fluctuations were smallest. Nevertheless, three-year moving averages were calculated of the modelled 
results in order to eliminate the most erratic residuals. The main findings may be summarised as 
followed. 
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5.1.- Total mortality 
Although the modelled values for the Western European countries appear to coincide almost perfectly 
with the observed ones within the range used to construct the models, this is not entirely the case, as the 
scaling of the graphs obscures some of the differences. The maximum deviance that was recorded was 
around 2,8% for men (French males, 1988) and 4,1% for women (Greek women, 1986), both 
equivalent to about 27 deaths per population of 100,000. Differences were also quite limited with 
regard to the two to six additional years that were used to validate the models. The most obvious 
discrepancies were for Finnish women (larger decline than predicted) and France (a levelling off 
instead of the predicted continuation of the decline in mortality). 
On the contrary, there were larger differences between the observed and modelled values for Eastern 
Europe. In maximum relative differences were 7,2% for Latvian men (1993) and 5,9% for Estonian 
women (also 1993), exactly when mortality was at its highest point. Absolute differences were 
therefore much higher than observed for Western Europe (in these two cases respectively 142 and 54 
deaths per population of 100,000). As one of the most important variables that was used to predict 
mortality for one year was mortality rate of the year before, this difference is not so surprising when 
there are large annual changes in the mortality rate as was the case here. For this reason were the 
predicted levels of mortality for the latest available years also different from the observed levels when 
there was a sudden trend break, although the modelled values generally followed the same trend as 
observed, albeit with a year’s delay and less acute. See for instance the result for Russian men. 
With respect to the projections, male total mortality in Western Europe is set to continue its decline as 
observed since the late 1970s. In some instances, this decline in the short term may be accelerated (e.g. 
in Greece and Italy) or continue at a slower pace (the four Nordic countries). Female mortality is not as 
likely to decline very rapidly and its current trend may level off (Austria, Switzerland, and Greece) or 
mortality may even increase (Finland). With respect to Eastern Europe most countries in the sample 
have clearly recovered from the mortality crisis of the 1990s, although in many cases their mortality 
levels are still above that of the mid-1980s. Nevertheless, predictions are that most mortality levels will 
continue to decline at a similar pace. Exceptions are Belarus, where still no decline as taken place at 
levels are predicted to remain at its current level until 2010; The Czech and Slovak Republics, where 
the sharp decline during the last decades are predicted to come to a halt; and Hungary, where a sharp 
increase in mortality is predicted. While large sex-differences exist in the absolute level of total 
mortality in Eastern Europe, there are few sex-differences in terms of relative mortality change between 
the beginning and the end of the current decade.  
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Figure 1.- Observed and modelled total mortality rate for a selection of Western and Eastern 
European countries, 1977/81-2010 
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5.2.- Lung cancer 
Although the quality of the smoking variable in the Western European analysis for lung cancer was 
not as optimal as desired due to the large number of estimations that were made, the absolute 
difference between the observed and modelled values was never more than 3 deaths per population of 
100,000 for men and 2 for women, although due to the very low level of mortality among women in 
most countries, relative differences were usually larger than observed for men (a maximum of 13,5% 
in Norway, in 1978). Even though no smoking data was used to model the Eastern European data, the 
modelled rates were also very similar to the observed ones with maximum differences of 6 per 
100,000 for men (Latvia, 1984) and 1 per 100,000 for women (Estonia, 1983 and 1996), when the 
lung cancer mortality rate was between 60 and 130 for Eastern European men and 5 and 30 for 
Eastern European women. 
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Figure 2.- Observed and modelled lung mortality rate for Western and Eastern European 
countries, 1977/81-2010 
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Somewhere in the 1990s most Western European countries began to see a drop in male lung cancer 
mortality. According to the projections, this is set to continue in the same linear function in the second 
half of this decade. In Norway, where mortality levels since the late 1980s have been stable at just 
under 50 deaths per population of 100,000, the decline is set to take place during the forecasted 
period. Western European women experienced a different smoking pattern than men, as smoking was 
popularised much later. For this reason, lung cancer mortality levels are still increasing in most 
countries, although a levelling off has either been recently observed or is predicted for the near future. 
For Denmark and Sweden a small decline is even predicted. While gender differences were very large 
for some countries in the beginning of the sample period, up to more than 100 deaths per population 
of 100,000 for Belgium, Finland and the UK, 30 years later this difference is decreasing fast and in 
the case of Norway, Sweden and the UK, set to converge by around 2010. 
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In Eastern Europe, the male lung cancer epidemic was at its height somewhat later and with generally 
higher levels than in Western Europe. Moreover, most predictions seem to suggest a levelling off in 
the decent decline. Female mortality levels are generally lower in the East than in the West, whereby 
for most countries the current and predicted trend would suggests a levelling off of the increase or 
slight decline in the mortality rate. In fact, the pattern (but not the absolute level) of the current (since 
the turn of the century) and predicted lung cancer mortality is very similar for men and women. With 
regard to the projections this comes with little surprise, as the value of the input variables are the same 
except for mortality at time t-1 (remember that there were no sex-specific smoking data). In other 
words, there are fewer (predicted) male-female differences in the pattern (but not absolute level) of 
lung cancer mortality in Eastern Europe than in Western Europe. 
 
 
5.3.- Heart disease 
What is striking with regard to the heart disease trend within Western Europe from the late 1970s 
until the latest available year (about 2003) is, with the exception of Greece, the uniformity (i.e. 
continual decline) between not only the countries, but also between men and women.  
 
Figure 3. Observed and modelled heart disease mortality rate for Western and Eastern 
European countries, 1977/81-2010 
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The difference between the observed and predicted values was therefore usually no more than a few 
percentage points and the model fitted the data for the additional years very well. For example, the 
absolute difference in Finland for the additional six years that were obtained to validate the model was 
never more than 6 deaths per population of 100,000 (or 1,9%) among men or 3/100,000 (or 1,6%) 
among women. 
In Eastern Europe, while some countries (e.g. Estonia and Latvia) show signs of recovery after the 
increase during the 1990s all but the Czech and Slovak Republics and Hungary experienced, in other 
countries mortality continues to increase (e.g. Russia) or show signs of levelling off (e.g. Bulgarian 
men). The differences between the observed and modelled rates are larger than in Western Europe, 
although there are no great discrepancies with the general mortality trend. Differences are largest 
around the period of sudden increases or decreases in mortality when the modelled trend tends to lag 
a year behind the observed trend. Only with regard to Bulgarian and Ukrainian men did the observed 
morality rate for the validation years not quite follow the modelled rate. With regard to the projected 
rates, there are basically three trends. Firstly, a continuation of the decline that has been observed 
throughout the entire study period in most of the Western European countries. The second observed 
trend is the levelling off in the rate of decline. In the case of Italy, where current rates are already low, 
this may suggest that, at least in the short term, possible further gains in survival from this disease are 
limited.  
In the case of Austria and Denmark this appears to be the effect of smoking, which hampers further 
decline. With regard to Hungary, where this trend is also predicted even though current levels are still 
relatively high, it may suggest that especially the social and economic conditions are still not right to 
allow heart disease to continue its rapid decline. The third observed trend is the sudden decline that is 
predicted in most Eastern European countries where the mortality rate has only recently showed signs 
of recovery or which will take place during the predicted period. Again, while absolute sex 
differences in heart disease mortality are large, the observed and proposed trends between men and 
women are similar.  
 
5.4.- Suicide 
Modelled and observed rates appear very similar in most countries. Minor differences are observed in 
most Eastern European countries and in Austria, Denmark and Norway, though no more than 1 or 2 
deaths per 100,000.  
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Figure 4. Observed and modelled suicide mortality rate for Western and Eastern European 
countries, 1977/81-2010 
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Perhaps the least reliable result is that of the Slovak Republic, as the modelled results for the last 
5 years for which data were available, including the three years that did not partake in the model 
sample, were consistently lower than the observed values. With regard to the projected level of 
mortality for Western Europe, a decline is foreseen in Italy, Norway, Sweden and for Belgium 
males, little change in the current level in Austria, Switzerland, France (men), Finland (women) 
Greece and the UK and a possible increase in Denmark, Belgium females and Finnish men. With 
regard to Eastern Europe absolute levels were on the whole substantially higher. This was 
especially the case for males, where some of the countries experienced a sharp rise during the 
mid-1990s as a result of economic and political uncertainty, although since then levels have 
declined or are set decline in the projected period. It is perhaps curious that in the Czech 
Republic, that throughout the study period had one of the lowest levels of suicide, levels are not 
predicted to change by much, while its neighbour the Slovak Republic where past suicide levels 
were very similar, a continual decline is expected. Other exceptions are Hungary, where levels 
are set to stabilise (and slightly increase among women), Russia and the Ukraine, where male 
levels are predicted to remain at the height that they have experienced since the early 1990s. In 
both Europe’s, there doesn’t seem to be a convergence between men and women in the mortality 
rate for suicide. 
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6.- Summary and conclusion 
The main purpose of this paper was to test cause-specific mortality models that were based on 
both mortality indicators and exogenous variables. These models were derived from earlier 
research that assessed the importance of socioeconomic and other factors on mortality 
differences across Europe over time and between countries to determine which factors should be 
incorporated into future mortality scenarios (Spijker, 2004). Western and Eastern Europe and 
men and women were analysed separately, whereby model estimates from the original sample 
were compared with recently obtained data. Subsequently short-term projections were produced 
on the basis of the model results. The time frame of the original analysis was from the late 
1970s/early 1980s to the second half of the 1990s, with projections to 2010. Because of the time 
lag between exposure and health effect of a particular variable, which, in the case of most causes 
of death, is often a matter of years, current observations were used for the short-term projections 
and no attempt was made to produce different scenarios. In those instances where predictions for 
the independent variables were necessary, usually the latest available value was held constant for 
the required years or, as in the case of GDPc and unemployment, it was based on published 
forecasts until 2006 and held constant thereafter when no time lag was required.  
Besides total mortality, causes of death were also analysed. For the purpose of this paper, only 
the results for lung cancer, heart disease and suicide were provided. The reason for studying 
causes of death is that they provide knowledge of disease determinants and can therefore be 
considered as the first step towards possible explanation for mortality differences. But also for 
projection purposes using cause-specific rather than total mortality trends has been preferred in 
the past, particularly for short-term forecasting, because of the simplicity of the parameterisation 
functions for mortality by cause and by the fact that epidemiological knowledge can be used in 
formulating hypotheses (Tabeau et al., 2001). 
Another important aspect of the analysis was the pooling of the countries. Due to the different 
political and economic past between Eastern and Western Europe several exogenous variables 
were not considered as being comparable, for which reason the analysis was split into two, 
although separating Europe into a northern, western, southern, central and a former Soviet Union 
cluster could have been another option. However, these clusters are more homogeneous, which 
may cause certain variables to become unimportant in explaining within-cluster differences even 
though they are known to cause international mortality differences (e.g. dietary factors when only 
analysing Mediterranean countries). 
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One important difference with the original models on which this paper is based was the use of 
lung cancer mortality as an indicator for life-time smoking exposure for the causes of death other 
than lung cancer that are also known to be associated with smoking. Although this meant that the 
coefficient for smoking of the lung cancer model could not be compared with the other models, it 
was considered to be a more reliable smoking indicator than when annual tobacco consumption 
data is used. Another variation from the earlier models was the simultaneous testing of the 
positive long-term and negative short-term health effect of alcohol for total mortality and heart 
disease. Results showed that at the population level part of the country and time differences in 
heart disease among Western European women and Eastern European men were explained by 
both current and lagged consumption of alcohol, while only the beneficial effects proved 
significant in the model for Western European men and Eastern European women.  
With regard to the results, the most important independent variable was perhaps mortality at time 
t-1. It was a conscious decision to include this as one of the explanatory variables, as it was 
considered that under normal conditions, mortality does not change radically from one year to 
the next, because intrinsically, the timing of death is determined by a multitude of factors across 
the life course, some of which originate even before birth and which cannot be unveiled with 
cross-sectional population-level data. On the other hand, it was thought that the yearly 
fluctuations in mortality or gradual changes could be modelled by exogenous variables, as these 
would be the result from more short-term economic, social and behavioural changes. Thus it was 
not surprising to see that the variable lag times that were calculated for the Eastern European 
models were often shorter than in Western Europe due to the economic, political and social 
uncertainties there in the 1990s. This particularly pertained to the economic variables, GDPc and 
income inequality, the latter of which even had an impact on total mortality, even though income 
inequality has only been high in recent years. With regard to the original models, each variable 
was significant in one or more of the cause-specific models, thus indicating that not only 
economic factors play a role in explaining mortality differences over time and between countries, 
but also social, environmental and behavioural factors, and not only for men, but also for women, 
and in different types of political and economic settings. 
For total mortality, lung cancer, heart disease and suicide, model values were tested against the 
original data, as well as newly obtained data in order to ascertain if the models could also be 
applied beyond the sample range. For total mortality differences were no more than 27 deaths per 
population of 100,000 for both men and women in the Western European sample countries, 
while larger discrepancies between the observed and modelled values were established for 
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several of the Eastern European countries. This was particularly the case around the years of 
mortality crisis and recovery, although only in terms of the magnitude and timing of the mortality 
change, as in general the modelled mortality trend was in the right direction. Results showed that 
in Western Europe, male mortality is set to continue its decline as observed since the late 1970s, 
either in accelerated fashion or at a slower pace, while female mortality is less likely to decline 
very rapidly and its current trend may level off in some countries or, in the case of Finland, 
mortality may even increase. In Eastern Europe total mortality is predicted to continue its decline 
since the mid- to late 1990s, with Belarus, Hungary and Russia as exceptions. Overall, there is 
still little sign of a narrowing in the sex difference in total mortality in Eastern Europe as is the 
case in Western Europe, even for the forecasted period. With respect to lung cancer, the most 
obvious result was that sex differences in mortality has already narrowed drastically in most 
Western European countries and is predicted to converge in Norway, Sweden and the UK, as 
male mortality continues to decline and female mortality to rise or level off. In Eastern Europe, 
lung cancer mortality is still a relatively unimportant cause of death among women, while male 
levels are generally higher than in Western Europe, and show little sign of declining in the near 
future. Also with regard to heart disease there were few differences between the modelled and 
observed mortality rates for the Western European models. The declining trend that is observed 
for most countries is set to continue, albeit at a slower pace in those countries with already low 
levels, particularly among women. Results could indicate a minimum level of about 75 deaths 
per population of 100,000 in the future, at least for women, although male levels are slowly 
converging. The latter also applies to Eastern Europe, but levels are still much higher there. 
Nevertheless, contrary to total mortality a continuation of the current decline is projected for all 
countries and for both men and women.  
The last result that was discussed was suicide. Again, the observed and modelled mortality rates 
were very similar, and for most Western countries both male and female levels are set to change 
very little, which means that the sex differences will remain about the same until the end of the 
projected period. In the case of Eastern Europe, patterns are much less uniform for both men and 
women, but it seems that levels are predicted to decline in those countries with the most 
favourable economic situation. 
The aim now is to seek ways to further improve the methodology of modelling cause-specific 
mortality with non-demographic variables and to integrate the results in a multidisciplinary 
population projection. It may be that the models are too general, as we know from the concept of 
competing causes of death and the associated problem of inaccuracies of the cause-of-death 
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statistic, that particularly at very old ages, the underlying cause of death is less the result of a 
clearly-defined aetiological (causal) path than the random result of a more generalised 
deterioration of the capacity for life (Rosenberg, 1993). Therefore, because mortality from 
chronic diseases increases with age and in an ageing population such as that of Europe most 
mortality occurs at old age, it may be best to exclude deaths above the age of 85 or 90. For these 
oldest-old only all-cause mortality should therefore be modelled. But also other age-groups 
should perhaps be modelled separately, for instance, infant mortality, ages 1-24 , 25-64, 65-84, as 
the models include exogenous variables and a variable will not have the same association with 
each age, e.g. unemployment has little relevance for the non-working age population, or the 
meaning of the association changes with age, e.g. industrial employment for infant mortality may 
be an indicator the parental socioeconomic context, while for adults this may indicate their own 
socioeconomic context. Finally, while the theoretically basis of integrating non-demographic 
factors in mortality models is discussed at greater length in the original PhD thesis (Spijker, 
2004), one aspect that should be elaborated more on in future is the link between the observed 
and predicted cause-specific mortality trends with the corresponding trends of the relevant 
independent variables.  
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